Richard Hampton

963 total citations
7 papers, 500 citations indexed

About

Richard Hampton is a scholar working on Molecular Biology, Virology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Richard Hampton has authored 7 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Virology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Richard Hampton's work include HIV Research and Treatment (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Richard Hampton is often cited by papers focused on HIV Research and Treatment (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Glycosylation and Glycoproteins Research (1 paper). Richard Hampton collaborates with scholars based in United States, Australia and Japan. Richard Hampton's co-authors include James E. K. Hildreth, Dzung Nguyen, Zhaohao Liao, Zhiqiang An, Fubao Wang, William R. Strohl, John Fisher, Peter Haytko, Neal A. Halsey and Nan Wei and has published in prestigious journals such as Journal of Virology, Journal of Pharmacology and Experimental Therapeutics and Journal of Immunological Methods.

In The Last Decade

Richard Hampton

7 papers receiving 488 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Hampton United States 6 264 178 176 116 57 7 500
Salim Bounou Canada 11 155 0.6× 338 1.9× 259 1.5× 98 0.8× 60 1.1× 18 576
Kari A. Dilley United States 14 358 1.4× 194 1.1× 199 1.1× 130 1.1× 24 0.4× 14 630
Jean‐Stéphane Gatot Belgium 12 272 1.0× 467 2.6× 120 0.7× 115 1.0× 60 1.1× 16 706
Bibhuti Bhusan Roy Canada 11 404 1.5× 201 1.1× 421 2.4× 141 1.2× 31 0.5× 15 795
Xiaoxing Qiu United States 14 82 0.3× 173 1.0× 128 0.7× 149 1.3× 22 0.4× 26 562
Madoka Kuramitsu Japan 14 192 0.7× 237 1.3× 65 0.4× 61 0.5× 29 0.5× 44 462
Yoshiyuki Hakata Japan 12 322 1.2× 376 2.1× 293 1.7× 150 1.3× 58 1.0× 21 776
C A Bohan United States 13 257 1.0× 315 1.8× 464 2.6× 180 1.6× 65 1.1× 14 762
Rahel Byland United Kingdom 8 120 0.5× 210 1.2× 303 1.7× 133 1.1× 47 0.8× 8 489
Yoshii Nishino Japan 14 143 0.5× 119 0.7× 152 0.9× 103 0.9× 17 0.3× 27 422

Countries citing papers authored by Richard Hampton

Since Specialization
Citations

This map shows the geographic impact of Richard Hampton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Hampton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Hampton more than expected).

Fields of papers citing papers by Richard Hampton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Hampton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Hampton. The network helps show where Richard Hampton may publish in the future.

Co-authorship network of co-authors of Richard Hampton

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Hampton. A scholar is included among the top collaborators of Richard Hampton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Hampton. Richard Hampton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Glantschnig, Helmut, Kevin R. Scott, Richard Hampton, et al.. (2011). A Rate-Limiting Role for Dickkopf-1 in Bone Formation and the Remediation of Bone Loss in Mouse and Primate Models of Postmenopausal Osteoporosis by an Experimental Therapeutic Antibody. Journal of Pharmacology and Experimental Therapeutics. 338(2). 568–578. 71 indexed citations
2.
Stuckey, Bronwyn, P. Hugh R. Barrett, Richard Hampton, et al.. (2010). The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapy. Clinical Endocrinology. 73(4). 497–501. 2 indexed citations
3.
Ebert, Tim, Sharon Smith, Desmond Clark, et al.. (2010). A fully human monoclonal antibody to Staphylococcus aureus iron regulated surface determinant B (IsdB) with functional activity in vitro and in vivo. Human Antibodies. 19(4). 113–128. 47 indexed citations
4.
Su, Bin, Renee Hrin, Barrett R. Harvey, et al.. (2007). Automated high-throughput purification of antibody fragments to facilitate evaluation in functional and kinetic based assays. Journal of Immunological Methods. 322(1-2). 94–103. 10 indexed citations
5.
Liao, Zhaohao, et al.. (2001). Lipid Rafts and HIV Pathogenesis: Host Membrane Cholesterol Is Required for Infection by HIV Type 1. AIDS Research and Human Retroviruses. 17(11). 1009–1019. 295 indexed citations
6.
Hildreth, James E. K., Richard Hampton, & Neal A. Halsey. (1999). Antibody-Dependent Cell-Mediated Cytotoxicity Can Protect PBMC from Infection by Cell-Associated HIV-1. Clinical Immunology. 90(2). 203–212. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026